羟基喜树碱脂肪乳的制备及其在人血浆中稳定性考察

被引:16
作者
董隽
郭建新
平其能
机构
[1] 中国药科大学药剂教研室
[2] 中国药科大学药剂教研室 南京
[3] 南京
关键词
羟基喜树碱; 脂肪乳; 内酯型; 羧酸盐型;
D O I
暂无
中图分类号
R94 [药剂学];
学科分类号
100702 [药剂学];
摘要
目的:制备羟基喜树碱(HCPT)静脉注射脂肪乳,研究其在人血浆中对内酯型药物的保护作用。方法:采用乳化均质法,以注射级大豆油为油相,大豆卵磷脂为乳化剂制备O/W型的HCPT脂肪乳;测定乳剂的粒径和Zeta电位,考察含药脂肪乳的稳定性。通过体外血浆实验研究脂肪乳和注射液中的药物在人血浆中的稳定性。结果:HCPT静脉注射脂肪乳的物理稳定性良好,含量为(78.6±1.1)mg·L-1,平均粒径为(161.7±2.4)nm,Zeta电位为(-42.4±1.1)mV,115℃高压灭菌30min脂肪乳性状维持良好。与普通HCPT注射液相比,4h内脂肪乳可以显著降低血浆中药物内酯型向羧酸盐型的转化速率。结论:HCPT静脉注射脂肪乳剂可以显著提高血浆中内酯型药物的比例,从而提高药物的抗癌活性。
引用
收藏
页码:720 / 723
页数:4
相关论文
共 5 条
[1]
Simple non-ion-paired high-performance liquid chromatographic method for simultaneous quantitation of carboxylate and lactone forms of 14 new camptothecin derivatives[J] Kazumi Sano;Megumi Yoshikawa;Shinya Hayasaka;Kurita Satake;Yoji Ikegami;Hisahiro Yoshida;Toshihisa Ishikawa;Seigo Sawada;Shinzo Tanabe Journal of Chromatography B 2003,
[2]
Liquid chromatography determination of 10-hydroxycamptothecin in human serum by a column-switching system containing a pre-column with restricted access media and its application to a clinical pharmacokinetic study[J] Jun Ma;Zheng-Ping Jia;Qiang Zhang;Jun-Jie Fan;Ning-Xi Jiang;Rong Wang;Hua Xie;Juan Wang Journal of Chromatography B 2003,
[3]
Simultaneous determination of the lactone and carboxylate forms of the camptothecin derivative CPT-11 and its metabolite SN-38 in plasma by high-performance liquid chromatography[J] Daniel F. Chollet;Laurent Goumaz;Alain Renard;Guy Montay;Laurent Vernillet;Valdo Arnera;David J. Mazzo Journal of Chromatography B: Biomedical Sciences and Applications 1998,
[4]
Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin; an inhibitor of topoisomerase I[J] Ruiwen Zhang;Yufeng Li;Qiuyin Cai;Tiepu Liu;He Sun;Brandon Chambless Cancer Chemotherapy and Pharmacology 1998,
[5]
Stabilization of 10-Hydroxycamptothecin in Poly(lactide-co-glycolide) Microsphere Delivery Vehicles[J] Anna Shenderova;Thomas G. Burke;Steven P. Schwendeman Pharmaceutical Research 1997,